Community-acquired pneumonia (CAP) is the leading cause of death among infectious
diseases and an important health problem, having considerable implications for healthcare …

Severe pneumonia is associated with high mortality (short and long term), as well as
pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of …

Angiotensin-converting enzyme (ACE) inhibitors and statins may potentially benefit patients
with viral infections and pneumonia. Our study aimed to evaluate the impact of ACE …

Background Viral infections of the respiratory tract represent a major global health concern.
Co-infection with bacteria may contribute to severe disease and increased mortality in …

The epidemic that broke out in Chinese Wuhan at the beginning of 2020 presented how
important the rapid diagnosis of malnutrition (elevating during intensive care unit stay) and …

Although broad knowledge of influenza viral pneumonia has been established, the
significance of non-influenza respiratory viruses in community-acquired pneumonia (CAP) …

Respiratory virus infection can cause severe illnesses capable of inducing acute respiratory
failure that can progress rapidly to acute respiratory distress syndrome (ARDS). ARDS is …

Community-acquired pneumonia (CAP) is an important respiratory disease and the fifth
leading cause of mortality in Europe. The development of molecular diagnostic tests has …

Introduction Pneumococcal disease (PD) significantly contributes to morbidity and mortality,
carrying substantial economic and public health burden. This article is a targeted review of …

Severe viral infections may result in severe illnesses capable of causing acute respiratory
failure that could progress rapidly to acute respiratory distress syndrome (ARDS), related to …